Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001810978 | SCV002050237 | likely pathogenic | not provided | 2021-04-07 | criteria provided, single submitter | clinical testing | The NF1 c. c.5269-1G>C variant (rs876660141), also known as c.5206-1G>C for NM_000267.3, is reported in the literature in an individual affected with neurofibromatosis type I (Bonatti 2017). This variant is also reported in ClinVar (Variation ID: 431653). This variant is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. This variant disrupts the canonical splice acceptor site of intron 37, which is likely to negatively impact gene function. Based on available information, this variant is considered to be likely pathogenic. References: Bonatti F et al. Patterns of Novel Alleles and Genotype/Phenotype Correlations Resulting from the Analysis of 108 Previously Undetected Mutations in Patients Affected by Neurofibromatosis Type I. Int J Mol Sci. 2017 Sep 29;18(10):2071. PMID: 28961165. |
Medical Genetics, |
RCV000497213 | SCV000588797 | likely pathogenic | Neurofibromatosis, type 1 | 2017-02-02 | no assertion criteria provided | clinical testing |